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Edited by George DeMartino
Desmosomes are prominent adhesive junctions present
between many epithelial cells as well as cardiomyocytes. The
mechanisms controlling desmosome assembly and remodeling
in epithelial and cardiac tissue are poorly understood. We
recently identified protein palmitoylation as a mechanism reg-
ulating desmosome dynamics. In this study, we have focused on
the palmitoylation of the desmosomal cadherin desmoglein-2
(Dsg2) and characterized the role that palmitoylation of Dsg2
plays in its localization and stability in cultured cells. We iden-
tified two cysteine residues in the juxtamembrane (intracellular
anchor) domain of Dsg2 that, when mutated, eliminate its
palmitoylation. These cysteine residues are conserved in all four
desmoglein family members. Although mutant Dsg2 localizes
to endogenous desmosomes, there is a significant delay in its
incorporation into junctions, and themutant is also present in a
cytoplasmic pool. Triton X-100 solubility assays demonstrate
that mutant Dsg2 is more soluble than wild-type protein. Inter-
estingly, trafficking of the mutant Dsg2 to the cell surface was
delayed, and a pool of the non-palmitoylated Dsg2 co-localized
with lysosomalmarkers. Taken together, these data suggest that
palmitoylation of Dsg2 regulates protein transport to the
plasma membrane. Modulation of the palmitoylation status of
desmosomal cadherins can affect desmosome dynamics.
Desmosomes are multiprotein complexes that serve as
points of contact for the intermediate filament cytoskeleton of
neighboring cells of a given tissue.Desmosomes are particularly
prominent in skin and cardiac tissue, and disruption of desmo-
somal adhesion results in a variety of epithelial blister pheno-
types and ventricular cardiomyopathy, respectively (1). The
transmembrane protein core of the desmosome is comprised of
the desmosomal cadherins, desmogleins, and desmocollins (2,
3). These single-pass transmembrane adhesion proteins inter-
act extracellularly to mediate cell-cell adhesion (4). The intra-
cellular domains of the desmosomal cadherins recruit desmo-
somal plaque proteins (plakophilins and plakoglobin) and
recruit the intermediate filament cytoskeleton via interactions
with plakin family members (i.e. desmoplakin). In humans,
there are four desmoglein genes (Dsg1–4). Dsg1, Dsg3, and
Dsg4 are expressed in complex stratified epithelial tissues,
whereas Dsg2 is widely expressed in a variety of epithelial tis-
sues as well as in cardiomyocytes (2, 5, 6). Disruption of desmo-
somal adhesion through inactivation of desmoglein adhesive
activity results in a variety of cardiocutaneous syndromes (7),
underlining the importance of desmogleins in themaintenance
of strong cell-cell adhesion.
Protein palmitoylation is a reversible posttranslational mod-
ification whereby a 16-carbon fatty acid (palmitate) is linked to
specific cysteine residues via a labile thioester linkage (8, 9).
Palmitoylation of cellular proteins is thought to influence pro-
tein function by increasing their associationwith cellularmem-
branes or membrane microdomains and thereby regulating
diverse protein activities, including protein localization, traf-
ficking, activity, and stability (10). Unlike other lipid moieties
added to cellular targets, palmitoylation of cysteine residues has
been shown to be a reversible posttranslational modification.
The best studied example of reversible protein palmitoylation is
that of H-RAS. This acylation-deacylation cycle is important
for the proper trafficking of H-RAS between the Golgi appara-
tus and the plasma membrane. Palmitoylation of both H-RAS
and N-RAS occurs on membranes of the Golgi apparatus and
increases their affinity for cellular membranes and promotes
trafficking to the plasmamembrane, where deacylation occurs,
leading to the return of the deacylated proteins to the Golgi
apparatus (11, 12).
Although the composition of the desmosome has been
extensively studied, relatively little is known regarding the
mechanisms controlling the assembly and remodeling of this
junction. We recently demonstrated that several desmosomal
components are palmitoylated in cultured cells and that pre-
venting the palmitoylation of plakophilin-2 and 3 resulted in
disruption of desmosomal adhesion through a dominant-neg-
ative mechanism (13). These findings suggest that palmitoyla-
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tion plays an important regulatory role in desmosome assem-
bly, stability, or adhesive strength. In this study, we char-
acterized the role of palmitoylation on the localization of Dsg2.
We identified two cysteine residues in the cytoplasmic tail of
Dsg2 as palmitoylated residues and determined that palmitoy-
lation affects the trafficking of Dsg2 to the plasmamembrane as
well as the stability of the protein.
Results
Previous work from our laboratory demonstrated that sev-
eral desmosomal components were palmitoylated in cultured
cells, including the desmosomal cadherins (13). We chose to
more closely examine the effects of palmitoylation on the local-
ization and dynamics of Dsg2. We generated Dsg2 fused to
monomeric enhanced green fluorescent protein (Dsg2/GFP) as
well as Dsg2/GFP mutants in which the cysteine residues pres-
ent in the cytoplasmic domain were mutated (Fig. 1A). When
stably expressed in A431 cells, wild-type Dsg2/GFP was palmi-
toylated whereas mutant desmoglein 2/GFP 7mut with all
seven cytoplasmic cysteine residues mutated was not (Fig. 1B).
Furthermore, restoring two cysteine residues (Cys-635 and
Cys-637) in the mutant construct Dsg2/GFP 5mut resulted in
the restoration of palmitoylation. Mutating only cysteine 635
and cysteine 637 (Dsg2/GFP CACS), leaving the other five cys-
teine residues intact, resulted in abrogation of palmitoylation
(Fig. 1B).
We further investigated the palmitoylation of cysteine 635
and 637 by generating single point mutants (Dsg2 C635A/GFP
andDsg2 C637S/GFP) fused to GFP and expressed these fusion
proteins in A431 cells. We performed mass tag labeling as
FIGURE 1. Cysteine residues in the IA domain of Dsg2 and Dsg3 are palmitoylated. A, the relative location of the seven cysteine residues present in the
cytoplasmic tail of Dsg2. The extracellular domain of the Dsg2 is not shown in detail. Dsg2/GFP is wild-type full-length Dsg2withmonomeric GFP fused to the
carboxyl terminus. Dsg2/GFP 7mut has all seven cysteine residues mutated. Dsg2/GFP 5mut retains Cys-635 and Cys-637 but has the five distal cysteines
mutated. Dsg2/GFP CACS contains only the mutations C635A and C637S. IA, intracellular anchor; LD, linker domain; RUD, repeat unit domain; TD, terminal
domain. B, A431 cells stably expressingwild-type Dsg2/GFP and the variousmutant Dsg2/GFPwere analyzed using the acyl biotin exchange assay. 10%of the
input lysate used for each pulldownwas loaded (left). Streptavidin-agarose pulldowns of biotin-labeled proteinswere also loaded (right). Immunoblot analysis
was performed using anti-GFP (JL-8) to detect Dsg2/GFP fusion proteins and anti-FLAG to detect FLAG-tagged Dsg3. C, A431 cells stably expressingwild-type
Dsg2/GFP or various point mutants (Dsg2 C635A/GFP, Dsg2 C637S/GFP, and Dsg2/GFP CACS) were analyzed by mass tag labeling. Immunoblot analysis was
performed using anti-GFP (JL-8) to detect Dsg2/GFP fusion proteins. The arrows indicate the bands migrating at the expected molecular weight for the
incorporation of two mPEG, one mPEG, or no mPEG moieties. Acyl biotin exchange assays and mass tag labeling assays were repeated three times using
independent cell cultures for each experiment. D, amino acid sequence alignment of the four human Dsg proteins. The predicted transmembrane segments
are boxed, and the cysteine residues corresponding to Cys-635 and Cys-637 of Dsg2 are indicated by arrows.
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described recently by Percher et al. (14) (Fig. 1C). A significant
pool of wild-type Dsg2/GFP migrated at a molecular weight
consistent with the incorporation of twomPEGmoieties, and a
faint band could be detected at the molecular weight corre-
sponding to the addition of one mPEG.2 Dsg2 C635A/GFP and
Dsg2 C637S/GFP were found to migrate at the molecular
weight corresponding to addition of a single mPEG moiety.
This analysis suggests that each palmitoylated cysteine is mod-
ified independently of the other and that each does not depend
on previous modification of the adjacent cysteine. In addition,
the results show that the majority of Dsg2 is palmitoylated on
both cysteine 635 and cysteine 637. Dsg2/GFP CACS did not
incorporate mPEG, consistent with the acyl-biotin exchange
results shown in Fig. 1B. Comparing the sequences of the
human desmoglein proteins (Dsg1, 2, 3, and 4) revealed that all
four proteins have cysteines in the positions that correspond to
Cys-635 and Cys-637 in Dsg2 (Fig. 1D). Mutating murine Dsg3
at the corresponding cysteine residues (i.e. Cys-640 and Cys-
642) also resulted in abrogation of palmitoylation (Fig. 1B).
These data demonstrate that palmitoylation of theDsg proteins
occurs at two sites corresponding to conserved cysteine resi-
dues in the intracellular anchor (IA) domain.
Next we determined the subcellular localization of wild-type
and mutant Dsg2/GFP proteins that were stably expressed in
A431 cells (Fig. 2). Wild-type Dsg2/GFP was localized in a
punctate staining pattern at cell-cell borders and co-localized
with the desmosomal plaque protein desmoplakin (Fig. 2,
A–C). Similarly, Dsg2/GFP 5mut, the construct with five sites
mutated that was still palmitoylated (Fig. 1B), co-localized with
desmoplakin at cell-cell borders in a punctate pattern (Fig. 2,
G–I). In contrast, Dsg2/GFP 7mut (Fig. 2, D–F) and Dsg2/GFP
CACS (Fig. 2, J–L), two Dsg2/GFP fusion proteins that were
palmitoylation-deficient, were largely localized at cell-cell bor-
ders in a linear pattern. A pool of these non-palmitoylated
Dsg2/GFP proteins was also localized in a perinuclear region.
Immunoblot analysis of cell lysates prepared fromA431 cells
expressing Dsg2/GFP and Dsg2/GFP CACS demonstrated that
each fusion protein is expressed at similar levels (Fig. 2M).
Comparing the Triton X-100 solubility of wild-type Dsg2/GFP
withDsg2/GFPCACS revealed an increase in the amount of the
CACS mutant present in the Triton X-100 soluble fraction
(70.6% of total  1.4%) (Fig. 2, N and O) compared with wild-
type Dsg2/GFP (54.1% of total  1.5%) and a decrease in the
amount of the insoluble pellet fraction.
Palmitoylation-deficient Desmoglein 2 Displays Altered Des-
mosomeAssemblyDynamics—Using a calcium switch assay, we
tested the ability of Dsg2/GFP fusion proteins to incorporate
into desmosomes. We generated HaCaT keratinocytes stably
expressing wild-type Dsg2/GFP and the palmitoylation-defi-
cient mutant Dsg2/GFP CACS. Dsg2/GFP fusion proteins in
HaCaT cells grown inmedium containing low extracellular cal-
cium (50 M Ca2) localized in a diffuse cytoplasmic pattern
(Fig. 3, A and E). Upon elevating the calcium concentration to
2 Theabbreviationsusedare:mPEG,methoxy-PEG-maleimide;ARVC, arrhyth-
mogenic right ventricular cardiomyopathy; IA, intracellular anchor; NEM,
N-ethylmaleimide; HA, hydroxylamine; HPDP, N-[6-(Biotinamido)hexyl]-
3-(2-pyridyldithio)propionamide.
FIGURE 2. Palmitoylation-deficient Dsg2 localizes to a perinuclear sub-
cellular compartment.A–L, A431cells stably expressingwild-typeDsg2/GFP
(A–C), Dsg2/GFP 7mut (D–F), Dsg2/GFP 5mut (G–I), and Dsg2/GFP CACS (J–L)
were immunostained using anti-desmoplakin antibody, and co-localization
of GFP with desmoplakin is shown. The localization of Dsg2/GFP fusion pro-
teins was determined in at least three independent cultures grown on indi-
vidual coverslips. Scale bar10m.M, whole cell lysateswereprepared from
A431 cells expressingwild-type Dsg2/GFP and Dsg2/GFP CACS. Lysates were
subjected to immunoblot (IB) analysis. Immunoblot analysis was performed
using cell lysates prepared from three different cultures. These data demon-
strate equal expression of the GFP fusion proteins. N, A431 cells expressing
Dsg2/GFP andDsg2/GFPCACSwere separated into TritonX-100-insoluble (P)
and Triton X-100-soluble (S) fractions and subjected to immunoblot analysis
using anti-GFP.O, quantitation of soluble and insoluble fractions shown inN.
The lysates were prepared from four independent cultures, and immunoblot
analysis band intensities were collected using LiCor Odyssey infrared scan-
ning. Student’s t test was performed to determine differences in solubility (*,
p 0.05). DP, desmoplakin.
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1.8 mM (high calcium), within 30 min both Dsg2/GFP and
Dsg2/GFP CACS partially localized to cell-cell borders. After
3 h in high calcium-containing medium, wild-type Dsg2/GFP
was almost entirely found at cell-cell borders (Fig. 3C) and was
identical to the localization seen after 18 h in high calcium
medium (Fig. 3D). In contrast, a significant pool of Dsg2/GFP
CACS was still present in the cytoplasm at the 3-h time point,
and this cytoplasmic localizationwas still seen after 18 h in high
calcium-containing medium (Fig. 3, F–H). Quantification of
fluorescence intensity (Fig. 3I) revealed that wild-type Dsg2/
GFP fluorescence intensity at the plasma membrane increased
following addition of calcium to the culture medium with a
corresponding decrease in the cytoplasmic fluorescence inten-
sity. In contrast, Dsg2/GFPCACS fluorescence intensity at cell-
cell borders and the cytoplasm did not change dramatically
over the 18-h time course.
Palmitoylation-deficient Desmogleins Partitions with Lipid
Raft Components—Palmitoylation iswidely believed to increase
the association of proteins with cellular membranes and lipid
raft microdomains in particular (15). Proteomic analysis of iso-
lated lipid raft microdomains revealed an enrichment of pro-
teins known to be palmitoylated (16). Recent evidence has dem-
onstrated that numerous desmosomal components are also
associated with lipid rafts, including desmogleins (17–19). In
addition, mutation of the cysteine palmitoylated in plakophi-
lin-3 decreased plakophilin-3 association with lipid rafts (13).
We examined the ability of Dsg2/GFP, Dsg2/GFP CACS
Dsg3/FLAG, and Dsg3/FLAG CACA to associate with lipid
rafts by sucrose gradient centrifugation. Cell lysates were pre-
pared from A431 cells expressing wild-type desmoglein or
palmitoylation-deficient desmoglein mutants fused to GFP or
FLAG, and cell lysates were separated by sucrose gradient cen-
trifugation. Co-sedimentation of the GFP-tagged Dsg2 or
FLAG-tagged Dsg3 with the lipid raft component Caveolin1
was examined by immunoblot analysis (Fig. 4). Wild-type Dsg2
(Fig. 4A) and Dsg3 (Fig. 4B) partition with the lipid raft compo-
nent caveolin-1 in fractions 4 and 5, indicating an association
with lipid raft components. Palmitoylation-deficient Dsg2 and
Dsg3 also partition to fractions containing caveolin-1, demon-
strating that these mutant are also capable of associating with
lipid raftmicrodomains. These data suggest that palmitoylation
of the desmogleins is not the primary mechanism directing
these transmembrane proteins to lipid raft microdomains and
that other, still unidentified mechanism are likely responsible
for lipid raft targeting of these desmosomal cadherins.
Palmitoylation-deficient Desmoglein-2 Partially Co-localizes
with Golgi Compartment and Lysosomal Markers—We sought
to identify the perinuclear subcellular compartment to which
the Dsg2/GFP CACS fusion protein localized. We compared
the localization of wild-type Dsg2/GFP and Dsg2/GFP CACS
with that of the Golgi network using antibodies specific for the
trans Golgi network marker protein Golgin-97. Golgin-97 par-
tially co-localized with the GFP signal in A431 cells expressing
Dsg2/GFP CACS (Fig. 5, E–H), whereas there was no discerni-
ble co-localization with the wild-type Dsg2/GFP fusion protein
(Fig. 5,A–D). Additionally, we examined the ability of theDsg2/
GFP fusion proteins to co-localize with the lysosomal marker
Lamp-1. Lamp-1 partially co-localized with Dsg2/GFP CACS,
suggesting that the pool ofDsg2/GFPCACS associatedwith the
Golgi compartment is being degraded by a lysosomal pathway
(Fig. 6, E–H). No co-localization was observed between wild-
type Dsg2/GFP and Lamp-1 (Fig. 6, A–D).
FIGURE 3.Palmitoylation-deficientDsg2/GFPCACS showsdelayed incor-
poration into desmosomes. A–H, HaCaT keratinocytes stably expressing
wild-type Dsg2/GFP (A–D) and Dsg2/GFP CACS (E–H) were subjected to a
calcium switch assay. Calcium switch assays were performed three times
using different cell cultures on three different days. Subcellular localization of
the GFP fusion protein was determined at the indicated times following ele-
vation of the extracellular calcium concentration to 1.8 mM. Scale bar  10
m. I, the fluorescence intensity was measured at cell-cell borders and the
cytoplasm, total signal intensity was determined, and the percentage of sig-
nal in the cytosol andmembrane was determined. A minimum of 20 individ-
ual cells at each time point were examined, individual data points are shown,
and the standarddeviation is depictedby error bars. Note the continuedpres-
enceof cytoplasmicDsg2/GFPCACS. Anunpaired Student’s t testwas used to
determinedifferences in thepercentageof cytoplasmic signal after overnight
addition of calcium (*, p 0.0001).
FIGURE 4. Palmitoylation-deficient desmogleins associate with lipid raft
microdomains. A and B, cell lysates were prepared from A431 cells express-
ing Dsg2/GFP or Dsg2/GFP CACS (A) and A431 cells expressing Dsg3/FLAG or
Dsg3/FLAGCACA (B). Lysateswere separated by sucrose gradient centrifuga-
tion, and fractions were analyzed by immunoblot analysis and anti-GFP and
anti-FLAG. The presence of caveolin-1 (Cav1) in fractions 4 and 5 identify lipid
raft-containing fractions.
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Palmitoylation-deficient Dsg2 Is Degraded More Rapidly
ThanWild-type Dsg2—We compared the stability of wild-type
Dsg2/GFP and Dsg2/GFP CACS by treating cells with the pro-
tein synthesis inhibitor cycloheximide. Cell lysates were pre-
pared after various times of growth in medium containing
cycloheximide, and Dsg2/GFP levels were compared by immu-
noblot analysis (Fig. 7A). After 20 h in medium containing
cycloheximide, wild-type Dsg2/GFP was relatively stable, and
60% of the fusion protein remained. In contrast, only 40% of
Dsg2/GFP CACS remained after 20 h (Fig. 7B). As a loading
control, cell lysates were probed with anti-actin antibody. A
difference in degradation of the Dsg2/GFP CACS from that of
wild-type Dsg2/GFPwas observed as early as 3 h.We examined
the subcellular localization of Dsg2/GFP CACS after 3 h of
growth in medium containing cycloheximide and observed a
distinct clearing of the perinuclear compartment compared
with untreated cells (Fig. 7, C and D). Fluorescence recovery
after photobleaching analysis and cell surface biotinylation
assays revealed no difference in the internalization rates or in
the mobile fraction of Dsg2/GFP CACS compared with wild-
type Dsg2/GFP (data not shown). Taken together, these data
suggest that the perinuclear pool of Dsg2/GFP CACS is being
degraded rather than being transported to the plasma mem-
brane, whereas the Dsg2/GFP CACS residing in the desmo-
some is relatively stable despite not being palmitoylated. Thus,
palmitoylation of Dsg2 affects transport to the plasma mem-
brane but not its stability at the desmosome.
Discussion
Desmosomes are prominent adhesive junctions in a variety
of epithelial tissues, and disruption of desmosomal adhesion
has severe effects on tissue homeostasis (20–22) and important
consequences for the integrity of epithelial and cardiac tissues
(23, 24). In this study, we demonstrate that palmitoylation of
the cytoplasmic domain affects the transport of Dsg2 to the
plasma membrane, where it is incorporated into junctional
complexes. Interestingly, when incorporated into the desmo-
somal plaque, palmitoylation-deficient desmoglein was retained
at the junction in a manner indistinguishable from the wild
type. Failure to properly traffic to the plasma membrane
resulted in accelerated degradation of palmitoylation-deficient
Dsg2 through a lysosomal pathway.
Palmitoylation of cellular proteins has been shown to affect
protein localization and targeting to specific membrane com-
partments (25, 26). For example, reversible palmitoylation reg-
ulates Ras localization and activation through an acylation/
deacylation cycle (11). Previous studies from our laboratory
have demonstrated that palmitoylation-deficient plakophilins
fail to efficiently localize to the plasma membrane and act in a
dominant-negative manner to disrupt adhesion (13). Mecha-
nisms regulating the transport to and stability of desmogleins at
the plasmamembrane are beginning to be elucidated (27). Here
we have shown that preventing the palmitoylation of Dsg2 has
less pronounced effects on desmosome dynamics than when
plakophilin palmitoylation is disrupted. In the case of Dsg2,
mutation of the two cysteines in the IA domain that can be
palmitoylated results in defects in Dsg2 trafficking and degra-
dation. In contrast to the altered Dsg2 protein turnover shown
here, plakophilin-3 stability was not noticeably affected by pre-
venting its palmitoylation (data not shown).
For our experiments, we chose to examine the behavior of
Dsg2 in A431 cells because this cell line assembles numerous
desmosomes, and the composition of the junctions in this cell
line are well documented (28–30). A confounding issue with
our cell culture approach is the endogenous expression of other
desmosomal cadherins (Dsg3, Dsc2, and Dsc3) as well as
endogenously expressed Dsg2. Our experiments demonstrate
that A431 cells were capable of processing and transporting
wild-type Dsg2/GFP to sites of cell-cell contact where it co-
localized with endogenously expressed desmoplakin. Dsg2
palmitoylation-deficient mutants (Dsg2/GFP CACS and Dsg2/
GFP 7mut) also partially localized with desmoplakin but, in
contrast to the wild-type protein, also localized in a non-punc-
tate distribution at the plasma membrane and to a perinuclear
compartment. We suspect that Dsg2/GFP palmitoylation
mutants were able to associate with endogenous desmosomal
components, and when they were incorporated into desmo-
somes, theywere resistant to degradation (Fig. 7). The nature of
these interactions is currently unclear, but it is possible that
desmosomal cadherins interact through lateral interactions at
the plasma membrane. Palmitoylation of transmembrane pro-
teins has been proposed to affect local packing of the protein in
the context of the plasma membrane (26, 31). Thus, packing
of the transmembrane components of the desmosome in the
plane of the plasma membrane to assemble the desmosomal
plaque could be facilitated by palmitoylation of the desmo-
FIGURE 5.Dsg2/GFP CACS co-localizes with the Golgi network. A–H, A431
cells expressing wild-type Dsg2/GFP (A–D) and Dsg2/GFP CACS (E–H) were
stainedusinganti-Golgin-97. Co-localizationofGolgin-97with theGFP fusion
proteins is shown. The boxed areas in C andG are shown at highermagnifica-
tion in D and H, respectively. Immunofluorescence microscopy demonstrat-
ing co-localization was repeated three times. Scale bar 10 m.
FIGURE 6. Dsg2/GFP CACS partially co-localizes with lysosomes. A–H,
A431 cells expressing wild-type Dsg2/GFP (A–D) and Dsg2/GFP CACS (E–H)
were stained using anti-LAMP-1. Co-localization of Lamp-1 with the GFP
fusion proteins is shown. The boxed areas in C and G are shown at higher
magnification in D and H, respectively. Immunofluorescence microscopy
demonstrating co-localization was repeated three times. Scale bar 20 m.
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somal cadherins. Alternatively, desmosomal plaque proteins
(plakoglobin and plakophilins) may act to cluster the desmo-
somal cadherins at the plasma membrane, and these interac-
tions may be independent of desmoglein palmitoylation. How-
ever, based on our findings, we predict that palmitoylation of
the desmosomal cadherins promotes propermembrane target-
ing and incorporation into stable desmosomal plaques.
Palmitoylation has been shown to affect protein association
with membranes in a number of divergent systems (25). One
consequence of disrupted Dsg2 palmitoylation could be altered
retention time at the plasmamembrane.We tested the effect of
protein palmitoylation on the ability of Dsg2/GFP to maintain
plasma membrane association by fluorescence recovery after
photobleaching analysis. Analysis of the Dsg2/GFP localized at
cell-cell contacts revealed no difference in fluorescence recov-
ery between wild-type Dsg2/GFP and Dsg2/GFP CACS. Addi-
tionally, we performed cell surface biotinylation assays and
again observed no significant difference in the rates of internal-
ization of the Dsg2/GFP fusion proteins (data not shown).
These results show that the stability of Dsg2 at the cell surface is
not affected by loss of palmitoylation.
Palmitate is added to specific cysteine residues through the
action of palmitoyl acyltransferase activity. Recent studies have
identified the DHHC family of proteins as palmitoyl acyltrans-
ferases (32). There are 23 evolutionarily conserved ZDHHC
genes in mammals; recent studies have demonstrated that
deregulation of several ZDHHC proteins is linked to carcino-
genesis (9) and skin differentiation (33–35). The substrate spec-
ificity of the different ZDHHCs is currently unknown. We
hypothesize that a limited number of ZDHHCs present in the
Golgi compartment are responsible for palmitoylation of the
desmogleins. Identification of these palmitoyl acyltransferases
is a source of ongoing investigation, and targeted inhibition of
the relevant ZDHHC is likely to have effects on desmosome
assembly and dynamics.
At the beginning of our study, we examined the conservation
of cysteine residues present in the cytoplasmic domain of des-
mogleins, and it was interesting to note that, in addition to the
membrane-proximal cysteines in Dsg2, there were several other
cysteineswell conserved across different species. In particular, the
two cysteines present near the plakoglobin interaction domain
(human Dsg2 cysteines 813 and 814) in the ICS domain are con-
served in all members of the desmoglein family. These cysteines
are also present in the ICSdomain of the desmocollins.Aprevious
study had shown that cysteine 813 in humanDsg2wasmutated in
arrhythmogenic right ventricular cardiomyopathy patients (36).
When cysteine 813 was mutated to arginine, the authors noted
abnormal migration of the protein in SDS-PAGE and speculated
that this cysteine may be posttranslationally modified. Although
adjacent Cys residues are candidates for palmitoylation, we found
no evidence that these cysteines are palmitoylated in either Dsg2
or Dsg3 (Fig. 1). Preliminary studies suggest that this motif in
Dsc2a isalsonotpalmitoylated.3However,ourexperimentsdonot
exclude the possibility that these residues in the desmosomal cad-
herins aremodified in some othermanner, as Cys residues can be
modified in many ways (37, 38).
In the future, it will be beneficial to determine the mecha-
nisms regulating desmosomal cadherin palmitoylation and the
effect this posttranslational modification has on desmosome
3 B. J. Roberts, R. A. Svoboda, K. R. Johnson, and J. K. Wahl, manuscript in
preparation.
FIGURE 7. Palmitoylation-deficient Dsg2/GFP CACS is degradedmore rapidly thanwild-type Dsg2/GFP. A, A431 cells expressing wild-type Dsg2/GFP or
Dsg2/GFP CACS were grown in medium containing 30 g/ml cycloheximide (CHX) for the indicated times. Cell lysates were prepared, and equal protein was
loaded for immunoblot analysis (cycloheximide treatments were performed in triplicate, and representative blots are shown). B, band intensities were
collected using Odyssey infrared scanning of three independent experiments. Error bars represent the standard deviation. C and D, subcellular localization of
Dsg2/GFP CACS stably expressed in A431 cells that were grown in control medium and in medium containing 30 g/ml cycloheximide for 3 h.
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assembly and dynamics. Our study focused on Dsg2 palmitoy-
lation in epithelial cells, but the effect of Dsg2 palmitoylation in
cardiomyocytes has important implications for the under-
standing of Dsg2 mutations in the context of arrhythmogenic
right ventricular cardiomyopathy. Identification of the palmi-
toyl acyltransferases involved in the epithelium and cardiac tis-
sue will be an important component of this analysis.
Experimental Procedures
Cell Culture—The A431 cervical squamous cell carcinoma
cell line was obtained from the ATCC (Manassas, VA). A431
and HaCaT keratinocytes were routinely grown in DMEM
(Sigma) supplemented with 10% fetal bovine serum (HyClone
Laboratories, Logan, UT). Generation of retroviral particles
and retroviral infection have been described previously (13, 39,
40). Retrovirally infected cell populations were routinely grown
in DMEM containing 500 g/ml G418 (Mediatech Inc., Hern-
don, VA.). For calcium switch experiments, HaCaT cells were
grown inDMEMcontaining 50M calcium supplementedwith
10% dialyzed fetal bovine serum for at least 48 h prior to the
addition of calcium to a final concentration of 1.8 mM CaCl2.
Fluorescence images were collected at the indicated times fol-
lowing addition of calcium.
Antibodies—Anti-desmoplakin (20B6) was described previ-
ously (41). Commercially available antibodies were as follows.
Anti-GFP (clone JL-8 used at 1:1000 dilution for immunoblot
analysis) was purchased from Clontech. Anti-FLAG epitope
antibody (DYKDDDDK tag) was purchased fromCell Signaling
Technology (used at 1:1000, Boston, MA). Anti-Golgin-97
(clone CDF4) was purchased from Thermo Scientific (Rock-
ford, IL) and diluted 1:100 for immunofluorescence micros-
copy. Anti-Lamp-1 hybridoma (clone H4A3), anti--tubulin
(clone E7), and anti-actin (clone JLA20) were purchased from
the Developmental Studies Hybridoma Bank at the University
of Iowa. Hybridoma conditionedmediumwas prepared, stored
at80 °C, and used at 1:10 dilution for immunoblots and undi-
luted for immunofluorescence microscopy.
Detergent Extraction—Cell lysates were prepared as de-
scribed previously (41, 42). Triton X-100 soluble (s) and insol-
uble (p) fractions were isolated by first washing cell monolayers
with 1	 phosphate-buffered saline. Cells grown in a T25 flask
were scraped into 1 ml of Triton X-100-containing buffer (10
mM Tris-HCl (pH 7.0), 0.5% Triton X-100 (Sigma), 5 mM
EDTA, 2 mM EGTA, 30 mM sodium fluoride, 40 mM -glycer-
ophosphate, 10 mM sodium pyrophosphate, 2 mM sodium
orthovanadate, and 2 mM phenylmethylsulfonyl fluoride) and
incubated on ice while shaking for 15 min. The insoluble mate-
rial was collected by centrifugation for 15 min at 14,000 	 g.
The insoluble pellet was washed once with Triton X-100 lysis
buffer prior to resuspension of the pellet in 1 ml of SDS con-
taining buffer (10 mM Tris HCl (pH 8.0), 2% SDS, and 2 mM
EDTA). Lysates were prepared in Laemmli sample buffer, and
proteins were resolved by SDS-PAGE.
Lipid Raft Analysis—Cell lysates were prepared from A431 cell
lines expressingwild-type ormutant desmogleins and analyzed by
sucrose gradient centrifugation as described previously (43).
Generation of cDNA Constructs—Human Dsg2 cDNA
(GenBank no. BC099655) was purchased from the ATCC. The
 globin 5 untranslated sequence from pSPUTK (44) (Strat-
agene/Agilent Technologies, Santa Clara, CA) was added
upstream of the open reading frame. PCRwas used to remove the
stop codon and add sequences encodingmonomeric (45)GFP.To
generate monomeric GFP, we used PCR tomutate alanine 206 to
lysine (A206K)usingpEGFP-N3 (Clontech) as a template forPCR.
MonomericGFPwas added to the3 endof theDsg2open reading
frame. The fully assembled cDNA was ligated to the retroviral
expression vector LZBob neo (13, 46, 47) as an AfeI/NotI frag-
ment. LZBob neo is a modified version of LZRSms neo (46) con-
taining a modified multiple cloning site to facilitate cloning of
cDNAfragments. Full-lengthmurinedesmoglein3withacarboxyl-
terminal FLAG epitope has been described previously (48). The
Dsg3/FLAG cDNA was ligated to LZBob neo as described for
Dsg2/GFP. Dsg2 and Dsg3 point mutations were generated using
theQuikChange site directedmutagenesis kit (Stratagene/Agilent
Technologies). The modified cDNAs were completely sequenced
and shown to have no unintended changes.
Acyl Biotin Exchange andMass Tag Labeling—For acyl biotin
exchange, A431 cells expressing wild-type and mutant Dsg2/
GFP were grown to 80–90% confluence, and lysates were pre-
pared as described previously (49). Cells were harvested in lysis
buffer (150 mM NaCl, 50 mM Tris HCl (pH 7.4), 1% Triton
X-100, and 5 mM EDTA) containing 10 mM N-ethylmaleimide
(NEM, Sigma), and lysateswere collected by scraping on ice and
passed through a 25-gauge needle. Samples were chloroform-
methanol-precipitated, and the pellet was allowed to air-dry for
2–3min. The pellet was resuspended in 300l of 4% SDS buffer
(4% sodiumdodecyl sulfate, 50mMTris HCl (pH 7.4), and 5mM
EDTA) and diluted 4-fold in lysis buffer containing 10 mM
NEM. The samples were incubated at 4 °C overnight with gen-
tle agitation.NEMwas removed by performing three sequential
chloroform-methanol precipitations, and following the last
precipitation, the pellet was resuspended in 100 l of 4% SDS
buffer. The sample was divided in two, and one half was diluted
5-fold with lysis buffer containing 0.7 M hydroxylamine (HA)
(0.7Mhydroxylamine, 1mMHPDP-biotin, 0.2%TritonX-100, 1
mM PMSF, and 1	 protease inhibitor mixture (Sigma), and the
other sample was diluted 5-fold with buffer lacking hydroxyla-
mine (HA). Samples were incubated at room temperature
with gentle rocking for 1 h. Samples were chloroform-metha-
nol-precipitated three times, and the final pellets were resus-
pended in 240 l of 4% SDS buffer and diluted with 960 l of
low-HPDP-biotin buffer (150 mM NaCl, 50 mM Tris HCl (pH
7.4), 5 mM EDTA, 0.2 mM HPDP-biotin, 0.2% Triton X-100, 1
mM PMSF, and 1	 protease inhibitor mixture). Samples were
incubated at room temperature with gentle agitation for 1 h
prior to three sequential chloroform-methanol precipitations.
The final pellet was resuspended in 75 l of 2% SDS buffer (2%
SDS, 50 mM Tris HCl (pH 7.4), and 5 mM EDTA), and samples
were diluted to 0.1% SDS in lysis buffer containing 0.2% Triton
X-100, 1	 protease inhibitor mixture, and 1 mM PMSF. Protein
concentrations were determined, and equal amounts of protein
were added to streptavidin-agarose. Biotin-labeled proteins were
capturedonstreptavidin-agarose, andnon-specificallyboundpro-
teinswere removedbywashing thebeads in lysis buffer containing
0.1%SDSand0.2%TritonX-100.Capturedproteinswereboiled in
2	 Laemmli sample buffer and resolved by SDS-PAGE.
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For mass tag labeling, we followed the procedure described
by Percher et al. (14). Cell lysates were prepared in TEA buffer
(50 mM triethanolamine (pH 7.3), 150 mM NaCl, and 5 mM
EDTA) containing 4% SDS. 200 g of total cellular protein was
treated with a final concentration of 10 mM neutralized tris(2-
carboxyethyl)phosphine for 30 min with end-over-end rota-
tion. NEM was added to a final concentration of 25 mM, and
rocking continued for 2 h. NEM was removed by three rounds
of chloroform/methanol/H2O precipitation. The final pellet
was resuspended in TEA buffer containing 0.2% Triton X-100.
Samples were treated with 0.75 M NH2OH (HA) or without
hydroxylamine (HA) and incubated at room temperature for
1 h. Excess hydroxylamine was removed with one round of
chloroform/methanol/H2O precipitation, and the pellet was
resuspended in TEA buffer containing 0.2% Triton X-100 sup-
plemented with 1 mM mPEG (10 kDa, Sigma). Samples were
incubated with rocking for 2 h, and reactions were terminated
by one round of chloroform/methanol/H2O precipitation. The
final pellet was suspended in 1	 Laemmli sample buffer and
resolved by SDS-PAGE.
Immunofluorescence Microscopy—Cells grown on glass cov-
erslips were washed briefly in Hepes-buffered Hanks’ balanced
salt solution and fixed in 1% formaldehyde prepared from para-
formaldehyde in Hepes-buffered Hanks’ balanced salt solution.
Antibody staining was performed as described previously (13, 40,
41). GFP fluorescence at cell-cell borders was measured using a
Marianas live cell microscopy system consisting of a Zeiss Axio-
vert 200Mmicroscope and SlideBook 6.0 imaging software (Intel-
ligent Imaging Innovations Inc., Denver, CO) and equippedwith a
Stanford Research Systems laser ablation system (model NL100).
Imageswere collected using a Plan-Apochromat	63 (1.4 numer-
ical aperture) objective.Z stack imageswere collected.Raw images
were deconvolved and collapsed into a projection image prior to
determination of fluorescence intensity.
Statistical Analysis—Comparisons between two groups used
unpaired Student’s t test. For immunoblot analysis, samples
were prepared and resolved in triplicate, and band intensities
were collected using LiCor Odyssey infrared scanning.
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